Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeCynosureCynosure Expands Best-In-Class Potenza™ RF Microneedling System

Cynosure Expands Best-In-Class Potenza™ RF Microneedling System

Cynosure announced today the U.S. launch of its one-of-a-kind Fusion Tip, the newest addition to its best-in-class Potenza™ radiofrequency (RF) microneedling system.

With its dual-air chamber design, the Fusion Tip captures and releases air towards the skin with each pulse, enhancing the penetration of topicals into the skin by 67% for maximum results.

“We’re constantly challenging ourselves to drive innovation forward and deliver differentiated technologies that allow our customers to provide better, more customizable treatments for their patients,” said Todd Tillemans, Chief Executive Officer of Cynosure. “The Fusion Tip is the first and only RF microneedling tip on the market designed to enhance the penetration of topicals deeper into the dermis, improving the quality of your skin. This is a real game changer for RF microneedling and we’re proud to be at the forefront of this next-level technology.”

The Fusion Tip is the latest addition to Cynosure’s Potenza system, the world’s first 4-mode RF microneedling device, which uses ultrafine needles and radiofrequency energy to penetrate the top layer of the skin, triggering the body’s natural healing process to regenerate new collagen and elastin. Unlike other treatments on the market, Potenza treatments can be performed on all skin types, anywhere on the body and any time of year. Now with the single-use, disposable Fusion Tip, practitioners can maximize topical penetration while tightening the skin through soft tissue coagulation, revolutionizing the standard microneedling treatment.

“Potenza’s new Fusion Tip enables me to confidently deliver topicals deeper in the dermis, allowing me to reach where it matters most,” said Dr. Deanne Mraz Robinson of Modern Dermatology in Westport, CT. “By enhancing the penetration of topicals into the skin, I am able to maximize patient results.”

Of the Potenza system’s four modes (monopolar or bipolar, delivered at either 1 MHz or 2 MHz frequency), the Fusion Tip operates in monopolar at 1 MHz for deep and wide RF delivery and enhanced tissue engagement and topical penetration. While three to five treatments at roughly four to six weeks apart are recommended, patients may notice improvements in their skin after the first or second treatment and will continue to see improvements six to 12 months post-treatment.

The Fusion Tip is commercially available in the U.S. and only compatible with Cynosure’s Potenza device.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy